AstraZeneca and Daiichi Sankyo submit BLA to FDA for lung cancer treatment

Discovered by Daiichi Sankyo, Datopotamab deruxtecan was co-developed by the company along with AstraZeneca. Credit: National Cancer Institute on Unsplash.